The general research approach of Berlin Institute of Health combines translational research with an overarching systems medicine approach. This means that results of basic research will be transferred into medical therapies, diagnosis, and prevention in a faster and more targeted way, and clinical observations will be taken up more quickly by basic research. In other words, a knowledge transfer occurs "from bench to bedside and from bedside to bench". Research results may stem from various specialized areas – medicine, biology, chemistry, physics, mathematics, information technology, and the social sciences.

Systems medicine is based on an understanding that the human body is a complex system consisting of dynamic, interconnected networks of molecules, cells, and tissues. Research in systems medicine involves the study of molecular mechanisms in the human body in an integrative manner. Rather than diseases being understood as the malfunction of individual cells or organs, attention is paid to overarching processes influencing both health and disease. Clinical symptoms can have a number of molecular causes, and inversely a genetic defect can spark various diseases. For example, inflammatory disease can affect various organs including the skin, the intestines, and the lungs.

Systems medicine at BIH means pursuing a process of reciprocal exchange between basic biomedical research, clinical research, and medical practice. Establishing this process thus forms an essential part of fulfilling our mission to make scientific and technological developments in systems medicine accessible for designing new preventive measures, diagnosis, and therapy.

Research groups at BIH

People are at the heart of BIH’s work, and we aim to attract, develop and retain the brightest minds of trans ­lational research and management.

Read more

Sektionen + Wiss. Infrastruktur

Events

    • Berlin Organoid Symposium 2026 Brings Together International Research Community

      Organised by Prof. Ludovic Vallier’s research group at the Berlin Institute of Health at Charité (BIH), with Dylan Liabeuf, Anastasiia Maksiuk, Daniella Fradin and Katja Püstow leading the organisation, the second Berlin Organoid Symposium brought together over 220 international scientists at Bayer…

      Read more
      • New Research Group at BIH: AI in Healthcare and Life Sciences

        In July 2026, Dr. Benjamin Wild took over as head of the new research group “AI in Healthcare and Life Sciences” at the Berlin Institute of Health at Charité (BIH). He has been conducting research since 2021 at the Center of Digital Health at the Berlin Institute of Health at Charité (BIH), which is…

        Read more
        • International Award for Research into a Rare Form of Ovarian Cancer

          A research team led by Prof. Dr. Kirsten Kübler at the Berlin Institute of Health at Charité (BIH) has received the Rhonda’s Award 2027 from the Mucinous Ovarian Cancer Coalition, worth $100,000, for its project investigating the origins of mucinous ovarian cancer. The researchers are studying which…

          Read more

        Contact